Sep 3 |
3 US Stocks Estimated To Be 12.8%-44.8% Below Intrinsic Value
|
Sep 2 |
Bayer Presents Encouraging Data From Late-Stage Cardiovascular Study
|
Sep 2 |
SNY's MS Drug Meets Goal in One Phase III Study; Misses in Two Others
|
Sep 2 |
Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gain
|
Sep 2 |
Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate
|
Sep 1 |
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
|
Aug 31 |
Eli Lilly and Company (LLY): Among Goldman Sachs’ Best Hedge Fund Stock Picks
|
Aug 31 |
S&P 500 Giants Meta, Eli Lilly Lead 5 Stocks Near Buy Points
|
Aug 31 |
3 No-Brainer Stocks to Buy in September
|
Aug 31 |
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
|